Littérature scientifique sur le sujet « ST2/IL-33 »
Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres
Consultez les listes thématiques d’articles de revues, de livres, de thèses, de rapports de conférences et d’autres sources académiques sur le sujet « ST2/IL-33 ».
À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.
Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.
Articles de revues sur le sujet "ST2/IL-33"
Dwyer, Gaelen K., Lisa R. Mathews, Anna Lucas, Bruce R. Blazar, and Heth R. Turnquist. "Recipient conditioning contributes to IL-33-driven Th1 alloimmune responses following rapid ST2 upregulation on donor CD4+ T cells during lymphopenia-induced proliferation." Journal of Immunology 200, no. 1_Supplement (2018): 55.4. http://dx.doi.org/10.4049/jimmunol.200.supp.55.4.
Texte intégralMatta, Benjamin, Jeremy Lott, Lisa Mathews, Brian Rosborough, and Heth Turnquist. "CD11c+ dendritic cells are required for IL-33-mediated expansion of ST2+Foxp3+ regulatory T cells in vivo (P1075)." Journal of Immunology 190, no. 1_Supplement (2013): 121.9. http://dx.doi.org/10.4049/jimmunol.190.supp.121.9.
Texte intégralZhao, Qing, and Guangjie Chen. "Role of IL-33 and Its Receptor in T Cell-Mediated Autoimmune Diseases." BioMed Research International 2014 (2014): 1–10. http://dx.doi.org/10.1155/2014/587376.
Texte intégralMatta, Benjamin, Jeremy Lott, Lisa Mathews, Brian Rosborough, Bruce Blazar, and Heth Turnquist. "IL-33 stimulates dendritic cell secretion of IL-2 that promotes selective expansion of ST2+Foxp3+ regulatory T cells (IRC5P.460)." Journal of Immunology 192, no. 1_Supplement (2014): 125.9. http://dx.doi.org/10.4049/jimmunol.192.supp.125.9.
Texte intégralSong, Yitian, Fangzhi Wei, Ying Liu, et al. "IL-33/ST2 Activation Is involved in Ro60-Regulated Photosensitivity in Cutaneous Lupus Erythematosus." Mediators of Inflammation 2022 (July 20, 2022): 1–15. http://dx.doi.org/10.1155/2022/4955761.
Texte intégralZhang, Xiaoli, Benjamin M. Matta, Dawn K. Reichenbach, Bruce R. Blazar, and Heth R. Turnquist. "Suppression of Tumorigenicity 2 (ST2) signaling is required for regulatory T cell control of Graft-vs. Host Disease." Journal of Immunology 196, no. 1_Supplement (2016): 140.20. http://dx.doi.org/10.4049/jimmunol.196.supp.140.20.
Texte intégralHan, Jae Ho, Chang-Hee Suh, Ju-Yang Jung, et al. "Serum Levels of Interleukin 33 and Soluble ST2 Are Associated with the Extent of Disease Activity and Cutaneous Manifestations in Patients with Active Adult-onset Still’s Disease." Journal of Rheumatology 44, no. 6 (2017): 740–47. http://dx.doi.org/10.3899/jrheum.170020.
Texte intégralDong, Yonghua, Hua Hu, Dandan Fu, et al. "Serum Expression of IL-33 and ST2 in Patients with Psoriasis Vulgaris." Archives of Iranian Medicine 24, no. 9 (2021): 689–95. http://dx.doi.org/10.34172/aim.2021.99.
Texte intégralJohnston, Laura K., Chia-Lin Hsu, Rebecca A. Krier-Burris, et al. "Eosinophil lineage commitment and IL-5-dependent expansion is regulated by IL-33 in mice." Journal of Immunology 196, no. 1_Supplement (2016): 191.7. http://dx.doi.org/10.4049/jimmunol.196.supp.191.7.
Texte intégralCao, Shujun, Xuyong Qin, Chengping Li, et al. "The IL-33/ST2 Axis Affects Adipogenesis Through Regulating the TRAF6/RelA Pathway." International Journal of Molecular Sciences 25, no. 22 (2024): 12005. http://dx.doi.org/10.3390/ijms252212005.
Texte intégralThèses sur le sujet "ST2/IL-33"
Arshad, Muhammad Imran. "Role of IL-33/ST2 axis in acute hepatitis." Rennes 1, 2012. http://www.theses.fr/2012REN1B103.
Texte intégralAlyahyaei, Zahraa. "The role of IL-33 and ST2 in early pregnancy." Thesis, University of Oxford, 2014. http://ora.ox.ac.uk/objects/uuid:a6fd7c02-feeb-4fe5-b8e1-5713a65653b9.
Texte intégralMurphy, Grace E. J. "IL-33 and ST2 in innate and adaptive airway inflammation." Thesis, University of Glasgow, 2015. http://theses.gla.ac.uk/6685/.
Texte intégralPitman, Nicholas Ian. "The role of IL-33 and ST2 in allergic airways disease." Thesis, University of Glasgow, 2010. http://theses.gla.ac.uk/1817/.
Texte intégralKewin, Peter. "The role of IL-33 and ST2 in innate and adaptive inflammation." Thesis, University of Glasgow, 2007. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.444379.
Texte intégralFerrari, Larissa Staurengo. "Participação da IL-33/ST2 em modelo de artrite séptica em camundongos." Universidade Estadual de Londrina. Centro de Ciências Biológicas. Programa de Pós-Graduação em Patologia Experimental, 2011. http://www.bibliotecadigital.uel.br/document/?code=vtls000163964.
Texte intégralLi, Xiaofei. "The IL-33/ST2 pathway in CNS : Traumatic brain injury and brain tumour." Thesis, Uppsala universitet, Institutionen för biologisk grundutbildning, 2012. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-183937.
Texte intégralAmôr, Nádia Ghinelli. "Papel do receptor ST2 no desenvolvimento de carcinoma espinocelular induzido quimicamente." Universidade de São Paulo, 2015. http://www.teses.usp.br/teses/disponiveis/25/25149/tde-26042016-112036/.
Texte intégralTariq, Mubashira. "IL-33/ST2 and tissue Treg/AREG pathways in the pathophysiology of HIV infection." Electronic Thesis or Diss., Paris 12, 2021. http://www.theses.fr/2021PA120017.
Texte intégralFanny, Manoussa. "Etude des mécanismes de l’inflammation pulmonaire lors de l’exposition aux nanoparticules ou la fumée de cigarette : implication des voies de signalisations des récepteurs ST2 et NLRP6." Thesis, Orléans, 2016. http://www.theses.fr/2016ORLE2057/document.
Texte intégralChapitres de livres sur le sujet "ST2/IL-33"
Borges, Amanda, Melissa Abreu, Camila Miguel, Javier Emilio Lazo-Chica, and Wellington Rodrigues. "EIXO IL-33/ST2 NA DOENÇA PERIODONTAL CRÔNICA NA SENESCÊNCIA: UM ESTUDO ANALÍTICO TRANSVERSAL." In Perspectivas em Saúde: Saberes epidemiológicos, Ciência e Comunidade. Editora Creative, 2021. http://dx.doi.org/10.53924/pswr.04.
Texte intégralActes de conférences sur le sujet "ST2/IL-33"
Church, Colin, Ammad Mahmood, Charles McSharry, Damo Xu, Andrew Peacock, and David J. Welsh. "An ST2/IL-33 Transgenic Mouse Model Of Pulmonary Hypertension." In American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a4975.
Texte intégralLi, J., J. M. Magat, J. L. Thomas, and J. P. Dumouchel. "Endogenous IL-33 and Its Auto-Amplification of IL-33/ST2 Pathway Play an Important Role in Asthma." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2945.
Texte intégralWang, Yang, and Bin Wang. "Research Progress of IL-33/ST2 Signaling Pathway in Cardiovascular Disease." In Proceedings of the 2018 8th International Conference on Management, Education and Information (MEICI 2018). Atlantis Press, 2018. http://dx.doi.org/10.2991/meici-18.2018.98.
Texte intégralCohen, Suzanne, Ian Scott, Jayesh Majithiya, et al. "LATE-BREAKING ABSTRACT: Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation." In Annual Congress 2015. European Respiratory Society, 2015. http://dx.doi.org/10.1183/13993003.congress-2015.oa292.
Texte intégralGordon, Erin D., Margaret Solon, Prescott Woodruff, and John V. Fahy. "Dysregulation Of IL-33 And ST2 In Stable Asthma And Acute Asthma Exacerbations." In American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a4269.
Texte intégralAsrat, S., Y. Mao, Y. Zhou, et al. "Itepekimab Binds to IL-33 With High Affinity, Prevents the Formation of IL-33/ST2/IL-1RAcP Signaling Complex and Blocks Mediators of Airway Inflammation." In American Thoracic Society 2023 International Conference, May 19-24, 2023 - Washington, DC. American Thoracic Society, 2023. http://dx.doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4478.
Texte intégralYu, S. L., Y. B. Huo, C. H. Huang, et al. "SAT0043 Il-33/st2-mediated inflammation in endothelial cell is directly aggravated by il-6 during lupus nephritis." In Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13–16 June 2018. BMJ Publishing Group Ltd and European League Against Rheumatism, 2018. http://dx.doi.org/10.1136/annrheumdis-2018-eular.6064.
Texte intégralScott, I. C., E. England, D. G. Rees, et al. "Tozorakimab: a dual-pharmacology anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction." In ERS International Congress 2022 abstracts. European Respiratory Society, 2022. http://dx.doi.org/10.1183/13993003.congress-2022.2467.
Texte intégralYu, S., and Y. Tao. "AB0056 Emerging role of IL-33/ST2 axis in endothelial cell injury of lupus nephritis." In Annual European Congress of Rheumatology, 14–17 June, 2017. BMJ Publishing Group Ltd and European League Against Rheumatism, 2017. http://dx.doi.org/10.1136/annrheumdis-2017-eular.1700.
Texte intégralAndersson, Cecilia, Premkumar Siddhuraj, Caroline Sandén, et al. "COPD patients display pronounced changes of IL-33 and ST2 expression in alveolar capillary phenotypes." In ERS Congress 2024 abstracts. European Respiratory Society, 2024. http://dx.doi.org/10.1183/13993003.congress-2024.oa1071.
Texte intégral